Results 151 to 160 of about 5,888,396 (230)

Dietary patterns and their relationship with hepatobiliary health in patients with nonalcoholic fatty liver disease and gallstone disease. [PDF]

Front Nutr
Yu Z, He W.
europepmc   +1 more source

Post‐Microbial Therapeutics for the Next Generation of Medicine

MicrobiologyOpen, Volume 15, Issue 5, October 2026.
Post‐microbial therapeutics: from microbial perturbation to host benefit. Post‐microbial therapeutics provide a function‐centered framework that links targeted microbial perturbation to changes in microbial modules and metabolites, followed by measurable host responses. Phages and phage‐derived interventions can selectively modify bacterial populations
Mohammad Nazrul Islam Bhuiyan, Maliha Momtaj   +1 more
wiley   +1 more source

METTL7A is a key regulator of hepatic lipid metabolism and nonalcoholic fatty liver disease progression. [PDF]

Sci Rep
Chen F, Yao L, Yang L, Li X, Zhou J, Li D, Wu Z, Chen P.   +7 more
europepmc   +1 more source

Association Between Nonalcoholic Fatty Liver Disease and the Risk of Cardiovascular Disease in the Middle-Age and Elderly Population of Northern China: A Cross-Sectional Study [PDF]

Xuebing Zhang,1 Lianjie Wang,1 Ge Wang,1 Jiayue Li,1 Yiming Mu,2 Shidong Wang,1 Xiaoran Li1 1Department of Endocrinology, Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing 100700, People’s Republic of China; 2Department of Endocrinology,
Li X, Li J, Mu Y, Wang S, Zhang X, Wang G, Wang L   +6 more
core  

Posttranslational Modifications of p62/SQSTM1 in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
Schematic illustration of p62 as a posttranslational modifications (PTMs)‐programmed integrator in homeostasis, pathogenesis, and therapeutic targeting. (Left) Homeostasis: In physiological states, p62, through various PTMs such as phosphorylation, ubiquitination, and acetylation, coordinates essential cellular functions.
Weikai Wang, Xin Jiang, Runing Qiu, Chandra Sugiarto Wijaya, Miaoqin Chen, Jin Wang, Liyuan Zhu, Hongchuan Jin, Lifeng Feng   +8 more
wiley   +1 more source

Nonalcoholic Fatty Liver Disease as a Risk Marker for Incident Type 2 Diabetes Mellitus: A Systematic Review. [PDF]

Cureus
Khamees MES, Ali EAM, Hassan Babiker EB, Saeed R, Elsamani EA, Mohamed FAY, Ahmed A.   +6 more
europepmc   +1 more source

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis

, 2019
Yue Sun,1 Weiran Dai,2 Yuzhen Liang,3 Pijian Yang,1 Qiong Yang,1 Min Liang,4 Ning Xia1,5 1Geriatric Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China; 2Department ...
Liang Y, Xia N, Dai W, Yang P, Liang M, Yang Q, Sun Y   +6 more
core  

Brown Adipose Tissue: Molecular Mechanisms of Regulation, Physiological Functions, and Therapeutic Targets

MedComm, Volume 7, Issue 10, October 2026.
This review systematically covers three core dimensions of brown adipose tissue (BAT): multilayered regulatory mechanisms governing brown adipocyte differentiation and phenotypic identity, physiological functions and signaling pathways in mediating thermogenesis and systemic metabolic crosstalk between BAT and multiple organs, and emerging clinical in ...
Xiaoli Deng, Yuanyuan Shen, Ying Sun, Lu Lu, Chongkui Sun   +4 more
wiley   +1 more source

Hepatoprotective Effects of Quercetin-Chitosan Nanoparticles on Nonalcoholic Fatty Liver Disease: In Vivo Study. [PDF]

Food Sci Nutr
Babaalizadeh B, Osanloo M, Tavassoli A, Zarenezhad E, Niknia S, Miladpour B.   +5 more
europepmc   +1 more source

Nonalcoholic Fatty Liver Disease

, 2006
Nonalcoholic fatty liver disease is a common condition associated with metabolic syndrome. It is the most common cause of elevated liver enzymes in U.S.
Holt, Jim, Bayard, Max, Boroughs, Eileen
core